Dow announces $100 million investment in specialty silicone manufacturing

Share:

Dow Chemical Co. (Midland, Mich.; www.dow.com) announced the advancement of a series of targeted investment projects totaling approximately $100 million by the end of 2027 to expand its global specialty silicones manufacturing and innovation capabilities. These investments reinforce the company’s commitment to supporting fast-growing end markets while strengthening innovation and supply chain resilience for customers worldwide.

The investments will expand Dow’s specialty silicones capabilities across the United States, China and Japan, focusing on cutting-edge silicones and processing capabilities to meet growing global demand in mobility, electronics and health care applications.

“These investments underscore Dow’s focus on scaling specialty silicones materials and bringing innovation closer and faster to our customers,” said Brendy Lange, president of Performance Materials & Coatings. “By expanding manufacturing and innovation capabilities in these strategic regions, we are investing to meet rising consumer demand, strengthening our global supply chain capabilities, and enabling customers to move faster from innovation to commercialization.

Investments include:

This completes the series of silicones investments previously disclosed at Dow’s Investor Day event in 2024, with updated timing of the projects reflecting evolving market demand and affordability factors.

Demand to specialty silicones continues to grow faster than GDP across mobility, electronics and medical applications, where product performance, supply reliability and technical capabilities are critical. Dow’s investments are designed to support these trends through regional, regional-to-regional manufacturing that aligns capacity with customer demand.

In mobility and electronics applications, the expanded capabilities support growing demand to high performance, reliable silicone solutions utilized in mobility intelligence modules, data centers and microelectronics, energy electronics, consumer electronics components, and cutting-edge security systems. In medical applications, the expanded footprint reinforces Dow’s value proposition of end-to-end regional supply, an increasingly crucial requirement to regulated and mission-critical items.

Collectively across these applications, regional manufacturing and technical support help customers enhance supply reliability while meeting evolving performance and qualification standards. They also enhance Dow’s ability to deliver consistent condition, accelerate commercialization, and provide customers globally with manufacturing scale close to key demand centers.

Dow is the world’s largest and most integrated silicones producer, with a world-class footprint across the Americas, Europe and Asia. Its strategic back-integration, diversified downstream portfolio, and sector–leading digital capabilities position the Company to meet rising demand and serve customers greater efficiently.

Previous

With Weak Cost-Side Support, Polyamide Filament Yarn Was Trading Sluggishly and Consolidating

Next

Cost-Driven to Supply-Demand Regression, the Phthalic Anhydride Market Declined in June

Quick inquiry

Create

Inquiry Sent

We will contact you soon